Prolonged Refractory ICU Delirium Successfully Treated With Valproic Acid: Case Report and Literature Review

J Pharm Pract. 2021 Dec;34(6):984-987. doi: 10.1177/0897190020953017. Epub 2020 Sep 10.

Abstract

Intensive care unit (ICU) delirium is characterized by acute onset of cerebral dysfunction with a change or fluctuation in baseline mental status. Delirium management includes non-pharmacologic and pharmacologic treatment. However at times, alternative pharmacologic treatment is warranted. Valproic acid (VPA) is a potential pharmacologic agent that can be utilized to treat ICU delirium, though there is a paucity of evidence for its use, especially in patients with a history of substance abuse. We review the literature on VPA use in ICU delirium, and describe a challenging case of a 27-year-old female with a history of substance abuse experiencing hyperactive ICU delirium for greater than a month, refractory to multiple treatment modalities, and successfully treated with VPA therapy.

Keywords: ICU delirium; hyperactive delirium; substance abuse; valproic acid.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antipsychotic Agents* / therapeutic use
  • Delirium* / diagnosis
  • Delirium* / drug therapy
  • Female
  • Humans
  • Intensive Care Units
  • Psychomotor Agitation / drug therapy
  • Valproic Acid / therapeutic use

Substances

  • Antipsychotic Agents
  • Valproic Acid